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•

• Design: Evidence-based quality improvement
project.
• Sample: Inpatient/Outpatient Oncology & float
Pool RNs.
• Methods:
• Identical pretest/posttest.
• Pretest measures nursing knowledge of
immunotherapy versus chemotherapy.
• Microteaching: focusing on
immunotherapy’s method of action and
differentiating between adverse events
associated with chemotherapy versus
immunotherapy.
• Posttest immediately after teaching.

•

•
•

•

Adverse effects of cancer therapies vary
based upon the drugs and treatment
modalities used.
Side effects/adverse events associated with
chemotherapy are much different than
immune related adverse events (IrAEs).
The major adverse events associated with
immunotherapy are ‘itis’ which may mimic
signs associated with neutropenic-associated
infection.
Early recognition of adverse events leads to
improved outcomes and decreased
hospitalizations.

PROBLEM STATEMENT/PURPOSE
• Many patients receive immunotherapy as a
part of their cancer treatment.
• Earlier research conducted at St. Joseph
Hospital Orange identified nursing knowledge
deficits regarding immunotherapy and IrAEs.
• This project measures the efficacy of microeducation as an effective method to educate
nurses about IrAEs.
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•

Correct number of chemotherapy side effects
/ adverse effects from cancer treatments preeducation: mean of 3.7 (SD = .6), posteducation: mean 3.9 (SD = .3). p < .0001.
Correct number of immunotherapy side
effects / adverse effects from treatments preeducation: mean of .03 (SD = .2), posteducation: mean 0.07 (SD = .3) p < .0001.

RESULTS
Pre
N = 29
Yes

No

Are the side effects of
27.6%
chemotherapy the same as
(8)
the adverse events of
immunotherapy?

69.0%
(20)

Are you familiar with the
48.3%
drug used to manage
(14)
moderate to severe cases
of immune related adverse
events, (IrAE’s)?

48.3%
(14)

Are you comfortable
recognizing side
effects/adverse events on
patients who are/have
been on treatment for
cancer?

75.9%
(22)

Post
N = 29

Pvalue

Yes

No

6.9% (2)

93.1% (27)

<. 001

CONCLUSIONS
•

86.2% (25)

13.8% (4)

.060

•
20.7% (6)

100.0% (29)

0.0% (0)

.083

•

Oncology nurses were knowledgeable about
side effects of chemotherapy before
education but benefited from microteaching
about IrAEs.
Education specific to immunotherapy and
IrAEs is essential for any RN who may be
caring for a patient who is receiving
immunotherapy.
Extend teaching about IrAEs to include
inpatient nurses throughout the hospital.

